Paper Contents
Abstract
In the past few decades, the pharmaceutical industry has been limited by the extent of cutting-edge research in pharmaceutical sciences, because the development of new drugs is a long and complex process accompanied by high risks and high costs . In other words, the current field of drug research and development (R&D) requires significant productivity improvements to shorten the cycle time and cost of drug development. Technologies 3D printing (3DP), is a method of manufacture whereby an object is built up layer by layer It includes multiple techniques, such as fused deposition modelling (FDM), hot melt extrusion (HME), solid state extrusion (SSE), stereolithography apparatus (SLA), digital light processing (DLP), selective laser sintering (SLS), vat polymerisation and binder jetting such as network pharmacology, RNA-sequencing (RNA-seq), high-throughput screening (HTS), or virtual screening (VS) have all accelerated the discovery of new targets, as well as new drugs to some extent Nevertheless, these technologies have rarely been significant contributors to the current process of new drug discovery. Thus, there is an urgent need for new technology to drive the development of new drugs
Copyright
Copyright © 2025 Vikas Chandra Mourya . This is an open access article distributed under the Creative Commons Attribution License.
